Approval · Notice of Compliance 5178 · 1995
SYNPHASIC: Notice of Compliance 5178
Issued October 31, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5178
- Date
- October 31, 1995
- Company
- Searle Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Oral contraceptive
Products in this notice
Medicinal ingredients
- NORETHINDRONE 0.5 MG per TAB
- ETHINYL ESTRADIOL 0.035 MG per TAB
- NORETHINDRONE 1 MG per TAB